DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option
ID: 359094Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359094
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Cancer Research Program (PRCRP) Career Development Award, specifically targeting early-career researchers via Fellow and Resident Options. This grant aims to support advancements in cancer research by funding projects that address critical issues relevant to military health, with a focus on specific PRCRP topic areas such as blood, gastroenterological, and neurological cancers. The total estimated funding for this initiative is approximately $6.72 million, with funding caps of $280,000 for one-year Resident projects and $560,000 for three-year Fellow projects. Interested applicants must submit a pre-application by June 19, 2025, followed by a full application due by July 3, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525PRCRPCDAFRO_GG.pdf
    The Department of Defense (DOD) announces the FY25 Peer Reviewed Cancer Research Program (PRCRP) Career Development Award for early-career researchers through the Fellow and Resident Options. This initiative supports advancements in cancer research by funding investigations that address key issues relevant to military health. Eligible applicants include early-career investigators and residency program participants. Each application must align with specific PRCRP topic areas and strategic goals, including blood, gastroenterological, neurological cancers, and more. Funding totals approximately $6.72 million, with caps of $280,000 for one-year Resident projects and $560,000 for Fellow projects extending over three years. The two-step application process involves submitting a pre-application (due June 19, 2025) and a full application (due July 3, 2025). Applicants must include comprehensive application materials detailing the research proposal, including a project narrative, technical and lay abstracts, and a career development plan. Moreover, applications emphasizing collaboration with military or federal agencies are encouraged, aligning research objectives with military health and readiness while avoiding clinical trial proposals. The program emphasizes the significance of mentorship and career development within the cancer research community, aiming to cultivate the next generation of scientists dedicated to addressing cancer's impact on military personnel and their families.
    Similar Opportunities
    Staff Research Program
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity for the Staff Research Program, aimed at engaging scientific staff in collaborative research with higher education institutions. This program seeks to enhance the professional competence of Army Research Office (ARO) scientists through hands-on, fundamental research in various scientific fields, including engineering, physical sciences, and life sciences, with a focus on advancing knowledge relevant to Army missions. Eligible applicants include institutions recognized for their scientific research capabilities, and the funding will be provided through cooperative agreements with award amounts ranging from $200,000 to $10 million. Proposals must be submitted via Grants.gov by June 2, 2030, and interested parties can contact Mr. William Creech at William.a.creech3.civ@army.mil for further information.
    National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health, through the National Cancer Institute (NCI), invites applications for Program Project grants (P01) aimed at fostering collaborative, multidisciplinary cancer research for the years 2023, 2024, and 2025. Applicants must propose at least three interrelated research projects and an Administrative Core, all centered around a common theme within the expansive field of cancer research, which includes areas such as cancer biology, prevention, diagnosis, treatment, and control. This funding opportunity is crucial for advancing cancer research and enhancing the effectiveness of collaborative efforts, with applications due by May 7, 2026. Interested parties can find more information and application guidelines at the provided link, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)," aimed at enhancing the training of a workforce to meet the nation’s biomedical and clinical research needs, particularly in cancer research. This program seeks applications that propose innovative educational activities, specifically hands-on cancer research experiences lasting 8 to 15 weeks, complemented by additional educational initiatives. With a funding ceiling of $300,000 per year for a project period of up to five years, the program encourages participation from underrepresented groups and aims to provide unique educational opportunities not covered by existing programs. Interested applicants can find more information and guidelines at the NIH website, with the application deadline set for January 25, 2026.
    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)." This funding aims to support innovative projects that develop technologies for analyzing and managing biospecimens in cancer research and clinical care, with a focus on proof-of-concept studies that demonstrate feasibility in areas such as cancer biology, early detection, and health disparities. The total estimated program funding is $4.7 million, with individual awards ranging from $50,000 to $150,000, and approximately 17 awards are expected to be made. Interested applicants can reach out to Dr. Kelly Crotty at Kelly.crotty@nih.gov or by phone at 240-255-0917 for further information, with applications due by April 10, 2026.
    Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Specialized Programs of Research Excellence (SPOREs) in Human Cancers, specifically for the fiscal years 2027, 2028, and 2029, under the P50 Clinical Trial Required grant program. This initiative aims to fund innovative translational research that enhances prevention, early detection, diagnosis, and treatment of organ-specific cancers or closely related cancer groups, utilizing advanced cellular, molecular, and genetic approaches. With an estimated total program funding of $25 million and the expectation of awarding 12 grants, interested applicants must submit their proposals by January 25, 2027, with the anticipated award date set for June 4, 2027. For further inquiries, applicants can contact Bradley T. Scroggins at bradley.scroggins@nih.gov or by phone at 240-276-7860.
    Notice of Intent to Publish Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity for the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will support early postdoctoral fellows in cancer research. This grant program aims to enhance the pool of qualified individuals from diverse backgrounds for careers in health-related research, particularly in cancer, by providing research training opportunities that do not require preliminary data. The program is significant for addressing cancer health disparities and enriching the scientific research experience for trainees transitioning from pre-doctoral to post-doctoral training. Interested applicants must identify a postdoctoral research mentor and submit their applications through their respective institutions, with the application deadline set for June 12, 2025, and an estimated award date of March 2, 2026.
    NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NCI Small Grants Program for Cancer Research (R03), aimed at supporting short-term cancer research projects that require limited resources. This funding opportunity encourages diverse research efforts, including pilot studies, secondary data analyses, and the development of research methodologies, with a maximum budget of $50,000 per year for projects lasting up to two years. The program is designed to address significant knowledge gaps in cancer research and is open to a wide range of applicants, including public, private, and foreign entities. Interested parties should note that the application period opens on January 24, 2025, with a submission deadline of February 24, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at fostering diversity within the cancer research workforce. This grant supports clinical scientists with doctoral degrees who are underrepresented in health-related research, providing salary support for a 3-5 year period to gain intensive research training in various cancer research fields, particularly focusing on health disparities. The program is designed to enhance the research capabilities of awardees, preparing them for independent research careers in basic biomedical, behavioral, or translational cancer research. Interested applicants should note that the application period opens on January 12, 2025, with a submission deadline of February 12, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-320.html.
    Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Cancer Research Education Grants Program, specifically for Curriculum or Methods Development under the R25 designation. This program aims to support innovative educational activities that enhance training in cancer research, focusing on projects that address the causes, diagnoses, prevention, treatment, and care of cancer patients and their families. The initiative is crucial for developing a skilled workforce to meet the nation's biomedical and clinical research needs. Eligible applicants include a diverse range of organizations, with a maximum funding amount of $150,000 per year for a project period of up to two years. Applications can be submitted starting December 25, 2023, with a closing date of January 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at training individuals with clinical doctoral degrees for impactful careers in health-related research, particularly in cancer studies. This program is designed to support individuals from underrepresented backgrounds in health-related sciences, providing them with a mentored research career development experience over a period of 3 to 5 years, focusing on biomedical, behavioral, and clinical research, including clinical trials. Successful applicants are expected to commit at least 75% of their time to the project and will receive funding for salary and research-related expenses, with applications due at specific intervals starting January 12, 2025. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-319.html.